India’s Screening Gap Is Too Large to Ignore

Only 0.9% of women in India have undergone screening for breast tumours, according to NFHS-5 data cited in the Hindustan Times analysis. At the same time, the disease accounts for about 26% to 27% of cancers diagnosed among Indian women. That gap has a cost. Many patients reach a hospital only after a lump grows, pain begins or the illness has spread. Treatment then becomes harder, longer and more expensive. India already screens adults over 30 for common non-communicable diseases through public health programmes. The problem is uneven reach. A national mission could bring awareness, examination, diagnosis and treatment into one working system instead of leaving women to navigate each step alone.

Screening Is Only the First Step

A screening test does not confirm cancer. It identifies a sign that needs closer examination. India’s public programme mainly uses clinical breast examination, in which a trained health worker checks for lumps or other changes. Mammography may be used based on age, risk, symptoms and medical advice. WHO generally places population mammography programmes in health systems that can also provide reliable follow-up. That last point matters. A woman may receive an abnormal screening result at a camp, but the process cannot stop there. She needs a clear referral, imaging when required, a biopsy if doctors advise it and a pathology report that guides treatment. The Hindustan Times article argues that core needle biopsy can provide more tissue information than fine needle aspiration in suitable cases. Doctors use that information to identify the tumour type and test markers that may affect treatment. Screening without follow-up can create fear without delivering care. A strong programme must measure how many women complete diagnosis and begin treatment, not just how many attend a camp.

Why Women Reach Hospitals Late

Low awareness is one reason. Fear is another. Many women notice a change but wait. They may worry about the cost, the reaction at home or the possibility of surgery. Some place family work first. Others live far from a centre that offers imaging and biopsy. The pattern is familiar in many Indian homes. A woman manages meals, school schedules and older relatives, then postpones her own appointment because the day is already full. One week becomes one month. Stigma also delays care. Some women fear that a diagnosis will affect marriage, work or how relatives treat them. These concerns are not solved by telling people to “be aware”. Health services must be private, respectful and easy to reach. Rural patients face added barriers. A primary centre may identify a suspicious lump, but the nearest imaging facility can be hours away. A second trip may be needed for biopsy and another for the report. Each journey costs money. It may also mean lost wages and arranging childcare. A national plan must account for those real barriers.

What a National Mission Should Include

India has run large public campaigns against polio, tuberculosis and HIV. A women’s cancer mission would need the same discipline, but with strong local delivery. ASHAs, ANMs and primary health teams can explain warning signs and guide eligible women towards screening. They also need training to recognise when a patient requires urgent referral. Mobile units can help districts with poor access, but vans alone will not solve the problem. Every unit needs a linked hospital, a booking system and a named person responsible for follow-up. Diagnostic capacity must grow too. District hospitals need trained radiologists, surgeons, pathologists and technicians. Laboratories must be able to process tissue and perform biomarker tests within a useful time. Digital records could track a woman from the first examination to treatment. The system should flag missed appointments and help health workers contact patients who need support. Patient navigators can make a major difference. They can explain reports, arrange appointments and help families understand where to go next. WHO says navigation can reduce delays and improve adherence in fragmented health systems. Quality checks are essential. A high screening number means little if examinations are rushed or abnormal findings disappear inside weak referral systems.

Technology Can Help but Cannot Replace Care

The Hindustan Times analysis points to portable imaging, thermal tools and other newer technologies. These may help services reach places where conventional equipment is limited. But technology needs evidence. A device should not enter a public programme only because it is portable or uses artificial intelligence. Health authorities must know how accurately it detects disease, how often it gives false alarms and whether hospitals can handle the referrals it creates. False positives can cause anxiety and unnecessary procedures. False negatives can give dangerous reassurance. No tool is useful without trained staff and a clear care pathway. India also needs reliable data. States should report screening coverage, abnormal results, completed biopsies, stage at diagnosis and time to treatment. Public data can show which districts are improving and where women are being left behind.

What Women Should Know Now

Women should seek medical advice for a new lump, breast thickening, nipple discharge, a change in shape, skin dimpling or a nipple that turns inward. These signs do not always mean cancer, but they should not be ignored. People with a strong family history or other risk factors may need advice earlier than routine public screening schedules. A doctor can explain which test fits the person’s age, symptoms and risk. Self-awareness helps, but it is not a replacement for clinical assessment. The goal is to notice a change and act without delay.

For The United Indian

Why This Matters

Women’s health cannot depend on whether a family lives near a cancer centre. Screening must lead to timely tests, clear answers and affordable treatment.

The Bigger Picture

Breast cancer screening can save more lives only when India connects community outreach with imaging, biopsy, pathology and care. Counting examinations is not enough.

Stay With Us

Follow The United Indian for clear health reporting that explains public policy, medical evidence and what national programmes mean for Indian families.